The policy also calls on the AMA to advocate that the FDA and Congress require drug manufacturers to create plans to ensure the continued supply of vital and life-sustaining medications and vaccines. The policy also supports the recommendations of the 2010 Drug Shortage Summit organized by the American Society of Health System Pharmacists, American Society of Anesthesiologists, American Society of Clinical Oncologists and the Institute for Safe Medication Practices.
Related Articles on Drug Shortages:
Severe Drug Shortages More Limited Than Previously Thought
Obama Orders FDA to Act on Drug Shortages
FDA Says Shortage Ends for Cancer Drug Cytarabine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.